Dr. Reddy’s (RDY) Launches Generic Allegra (SNY)
Tweet
Share
E-mailGet Alerts RDY Hot Sheet
Join SI Premium – FREE
Dr. Reddy’s Laboratories (NYSE: RDY) has launched OTC Fexofenadine HCl tablets on April 13, 2011.
The products are bioequivalent versions of sanofi-aventis’ (NYSE: SNY) Allegra tabs.
The products are bioequivalent versions of sanofi-aventis’ (NYSE: SNY) Allegra tabs.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sparton, Glen Eagle ink joint venture deal for Ontario silver mine
- Vishay launches two common mode chokes for automotive and industrial use
- Nebraska expands Tyler Technologies AI tools statewide after DMV pilot
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
